These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 21804441)
1. Murine antithymocyte globulin T-cell depletion is mediated predominantly by macrophages, but the Fas/FasL pathway selectively targets regulatory T cells. Neff KS; Richards SM; Williams JM; Garman RD; Ruzek MC Transplantation; 2011 Sep; 92(5):523-8. PubMed ID: 21804441 [TBL] [Abstract][Full Text] [Related]
2. In vivo characterization of rabbit anti-mouse thymocyte globulin: a surrogate for rabbit anti-human thymocyte globulin. Ruzek MC; Neff KS; Luong M; Smith KA; Culm-Merdek K; Richards SM; Williams JM; Perricone M; Garman RD Transplantation; 2009 Jul; 88(2):170-9. PubMed ID: 19623011 [TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells. Sayers TJ; Brooks AD; Lee JK; Fenton RG; Komschlies KL; Wigginton JM; Winkler-Pickett R; Wiltrout RH J Immunol; 1998 Oct; 161(8):3957-65. PubMed ID: 9780164 [TBL] [Abstract][Full Text] [Related]
4. The effect of murine anti-thymocyte globulin on experimental kidney warm ischemia-reperfusion injury in mice. Jang HR; Gandolfo MT; Ko GJ; Racusen L; Rabb H Transpl Immunol; 2009 Dec; 22(1-2):44-54. PubMed ID: 19682579 [TBL] [Abstract][Full Text] [Related]
5. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways. Benihoud K; Bonardelle D; Bobé P; Kiger N Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912 [TBL] [Abstract][Full Text] [Related]
7. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus. Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of tolerance induced by transforming growth factor-beta-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand. Kosiewicz MM; Alard P; Liang S; Clark SL Int Immunol; 2004 May; 16(5):697-706. PubMed ID: 15096489 [TBL] [Abstract][Full Text] [Related]
9. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways. Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307 [TBL] [Abstract][Full Text] [Related]
10. CD11c(high)CD8+ regulatory T cell feedback inhibits CD4 T cell immune response via Fas ligand-Fas pathway. Chen Z; Han Y; Gu Y; Liu Y; Jiang Z; Zhang M; Cao X J Immunol; 2013 Jun; 190(12):6145-54. PubMed ID: 23677464 [TBL] [Abstract][Full Text] [Related]
11. Human Fas-ligand expression on porcine endothelial cells does not protect against xenogeneic natural killer cytotoxicity. Matter-Reissmann UB; Sonntag KC; Gilli UO; Leguern C; Schneider MK; Seebach JD Xenotransplantation; 2004 Jan; 11(1):43-52. PubMed ID: 14962292 [TBL] [Abstract][Full Text] [Related]
12. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively. Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644 [TBL] [Abstract][Full Text] [Related]
13. Functional expression of Fas (CD95) protein in autoimmune lpr mice. Cui H; Ju ST; Sherr DH Cell Immunol; 1996 Nov; 174(1):35-41. PubMed ID: 8929452 [TBL] [Abstract][Full Text] [Related]
14. Correlation between natural and antibody-dependent cell-mediated cytotoxicity against tumor targets in the mouse. II. Characterization of the effector cells. Santoni A; Herberman RB; Holden HT J Natl Cancer Inst; 1979 Oct; 63(4):995-1003. PubMed ID: 384012 [TBL] [Abstract][Full Text] [Related]
15. B lymphocytes mediate Fas-dependent cytotoxicity in MRL/lpr mice. Bonardelle D; Benihoud K; Kiger N; Bobé P J Leukoc Biol; 2005 Nov; 78(5):1052-9. PubMed ID: 16204618 [TBL] [Abstract][Full Text] [Related]
16. Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells. Oshimi Y; Oda S; Honda Y; Nagata S; Miyazaki S J Immunol; 1996 Oct; 157(7):2909-15. PubMed ID: 8816396 [TBL] [Abstract][Full Text] [Related]
17. Overexpressed exogenous IL-4 And IL-10 paradoxically regulate allogenic T-cell and cardiac myocytes apoptosis through FAS/FASL pathway. Furukawa H; Oshima K; Tung T; Cui G; Laks H; Sen L Transplantation; 2008 Feb; 85(3):437-46. PubMed ID: 18301335 [TBL] [Abstract][Full Text] [Related]
18. Deletion of alloreactive T cells by veto cytotoxic T lymphocytes is mediated through extracellular signal-regulated kinase phosphorylation. Reich-Zeliger S; Eidelstein Y; Hagin D; Antebi YE; Seger R; Reisner Y Transplantation; 2010 Aug; 90(4):380-6. PubMed ID: 20595932 [TBL] [Abstract][Full Text] [Related]
19. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production. Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345 [TBL] [Abstract][Full Text] [Related]
20. In vivo blockade of the Fas-Fas ligand pathway inhibits cyclophosphamide-induced diabetes in NOD mice. Mahiou J; Walter U; Lepault F; Godeau F; Bach JF; Chatenoud L J Autoimmun; 2001 Jun; 16(4):431-40. PubMed ID: 11437491 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]